🎉 M&A multiples are live!
Check it out!

Sopharma Properties Valuation Multiples

Discover revenue and EBITDA valuation multiples for Sopharma Properties and similar public comparables like ASR Nederland, Waha Capital, and CVC Capital Partners.

Sopharma Properties Overview

About Sopharma Properties

Sopharma Properties REIT is a special purpose investment company for securitization of real estate.


Founded

2006

HQ

Bulgaria
Employees

1

Financials

Last FY Revenue $8.1M

Last FY EBITDA $9.1M

EV

$103M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 12K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Sopharma Properties Financials

In the most recent fiscal year, Sopharma Properties achieved revenue of $8.1M and an EBITDA of $9.1M.

Sopharma Properties expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Sopharma Properties valuation multiples based on analyst estimates

Sopharma Properties P&L

NTM Last FY FY 2025 FY 2026 FY 2027
Revenue XXX $8.1M XXX XXX XXX
Gross Profit XXX $6.4M XXX XXX XXX
Gross Margin XXX 79% XXX XXX XXX
EBITDA XXX $9.1M XXX XXX XXX
EBITDA Margin XXX 112% XXX XXX XXX
EBIT XXX $5.5M XXX XXX XXX
EBIT Margin XXX 68% XXX XXX XXX
Net Profit XXX $9.1M XXX XXX XXX
Net Margin XXX 112% XXX XXX XXX
Net Debt XXX n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Sopharma Properties Stock Performance

As of July 17, 2025, Sopharma Properties's stock price is BGN 8 (or $5).

Sopharma Properties has current market cap of BGN 176M (or $106M), and EV of BGN 170M (or $103M).

See Sopharma Properties trading valuation data

Sopharma Properties Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$103M $106M XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Sopharma Properties Valuation Multiples

As of July 17, 2025, Sopharma Properties has market cap of $106M and EV of $103M.

Sopharma Properties's trades at 12.6x EV/Revenue multiple, and 11.3x EV/EBITDA.

Equity research analysts estimate Sopharma Properties's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

Sopharma Properties's P/E ratio is not available.

See valuation multiples for Sopharma Properties and 12K+ public comps

Sopharma Properties Financial Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Market cap (current) $106M XXX $106M XXX XXX XXX
EV (current) $103M XXX $103M XXX XXX XXX
EV/Revenue n/a XXX 12.6x XXX XXX XXX
EV/EBITDA n/a XXX 11.3x XXX XXX XXX
EV/EBIT n/a XXX 18.7x XXX XXX XXX
EV/Gross Profit n/a XXX n/a XXX XXX XXX
P/E n/a XXX 11.7x XXX XXX XXX
EV/FCF n/a XXX 22.0x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Sopharma Properties Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Sopharma Properties Margins & Growth Rates

Sopharma Properties's revenue per employee in the last FY averaged $8.1M, while opex per employee averaged $0.9M for the same period.

Sopharma Properties's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Sopharma Properties's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Sopharma Properties and other 12K+ public comps

Sopharma Properties Operational Valuation Multiples

LTM NTM Last FY FY 2025 FY 2026 FY 2027
Revenue Growth n/a XXX n/a XXX XXX XXX
EBITDA Margin n/a XXX 112% XXX XXX XXX
EBITDA Growth n/a XXX n/a XXX XXX XXX
Rule of 40 n/a XXX n/a XXX XXX XXX
Bessemer Rule of X XXX XXX n/a XXX XXX XXX
Revenue per Employee XXX XXX $8.1M XXX XXX XXX
Opex per Employee XXX XXX $0.9M XXX XXX XXX
S&M Expenses to Revenue XXX XXX n/a XXX XXX XXX
G&A Expenses to Revenue XXX XXX n/a XXX XXX XXX
R&D Expenses to Revenue XXX XXX n/a XXX XXX XXX
Opex to Revenue XXX XXX 11% XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Sopharma Properties Public Comps

See public comps and valuation multiples for Asset Management comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Investcorp Capital XXX XXX XXX XXX XXX XXX
Waha Capital XXX XXX XXX XXX XXX XXX
ASR Nederland XXX XXX XXX XXX XXX XXX
CVC Capital Partners XXX XXX XXX XXX XXX XXX
Eurocommercial Props XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Sopharma Properties M&A and Investment Activity

Sopharma Properties acquired  XXX companies to date.

Last acquisition by Sopharma Properties was  XXXXXXXX, XXXXX XXXXX XXXXXX . Sopharma Properties acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Sopharma Properties

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Start Free Trial

About Sopharma Properties

When was Sopharma Properties founded? Sopharma Properties was founded in 2006.
Where is Sopharma Properties headquartered? Sopharma Properties is headquartered in Bulgaria.
How many employees does Sopharma Properties have? As of today, Sopharma Properties has 1 employees.
Is Sopharma Properties publicy listed? Yes, Sopharma Properties is a public company listed on BUL.
What is the stock symbol of Sopharma Properties? Sopharma Properties trades under SFI ticker.
When did Sopharma Properties go public? Sopharma Properties went public in 2006.
Who are competitors of Sopharma Properties? Similar companies to Sopharma Properties include e.g. Investcorp Capital, Waha Capital, ASR Nederland, CVC Capital Partners.
What is the current market cap of Sopharma Properties? Sopharma Properties's current market cap is $106M
Is Sopharma Properties profitable? Yes, Sopharma Properties is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.